Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Highlights • Pulmonary hypertension is common in end stage kidney disease. • There is little reported on vasodilator use in Group 1 PAH requiring dialysis. • Vasodilator therapy was relatively safe and effective in Group 1 PAH with end stage kidney disease. Abstract Background and objectives Pulmonary hypertension is commonly seen in end stage kidney disease and is most commonly due to elevated left heart pressures.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
